Close
Nordic 9Nordic 9

RV Invest (investor - Others)

Germany rvinvest.de
See something wrong or missing? Let us know
Offices:Ravensburg

RVI is a VC fund of Vetter Pharma family office

Average round investment:15.06M USD
Average number per year:1.3
Distribution: 2025 (2)2024 (1)2023 (1)
Portfolio companies: United Kingdom Valink TherapeuticsGermany Akribion TherapeuticsSweden Asgard Therapeutics
Mostly invests in: United Kingdom United Kingdom (2) Biotech (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to RV Invest

Name Criteria
United States Storm Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States MIG Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom David Prior
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Cyprus 33East
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Dolby Family Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Sweden Karl-Johan Persson
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United Kingdom Nigel Morris
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States VU Venture Partners
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States A.Capital Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Jim O’Neill
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top